Aptose Biosciences’ New AML Treatment Advances
PremiumCompany AnnouncementsAptose Biosciences’ New AML Treatment Advances
2M ago
APTO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
APTO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Aptose Biosciences files to sell common shares, no amount given
Premium
The Fly
Aptose Biosciences files to sell common shares, no amount given
2M ago
Aptose Biosciences price target lowered to $7 from $23 at H.C. Wainwright
PremiumThe FlyAptose Biosciences price target lowered to $7 from $23 at H.C. Wainwright
4M ago
Aptose Biosciences Secures $4.43 Million Funding
Premium
Company Announcements
Aptose Biosciences Secures $4.43 Million Funding
4M ago
Aptose Biosciences to sell 3.86M shares at $1.15 in registered direct offering
Premium
The Fly
Aptose Biosciences to sell 3.86M shares at $1.15 in registered direct offering
4M ago
Aptose Biosciences Unveils Q1 Results and Clinical Update
PremiumCompany AnnouncementsAptose Biosciences Unveils Q1 Results and Clinical Update
5M ago
Aptose Biosciences Announces Vital Update; Not SEC Filed
Premium
Company Announcements
Aptose Biosciences Announces Vital Update; Not SEC Filed
5M ago
Aptose Biosciences Enhances Executive Compensation and Roles
Premium
Company Announcements
Aptose Biosciences Enhances Executive Compensation and Roles
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100